Plain-English translation of NCT06584617 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a medical device called Berovenal®, a special gel dressing designed to help heal chronic foot ulcers in people with diabetes. The gel works by keeping the wound moist in a way that mimics the natural healing environment of damaged tissue. Researchers want to see if this treatment helps ulcers close faster and more completely than a standard gel dressing.
Diabetic foot ulcers are a serious complication that can be slow and difficult to heal, sometimes leading to infection or amputation. This trial exists to find out whether this new gel dressing can speed up healing and improve outcomes for people living with these stubborn wounds.
You likely qualify if…
You likely don't qualify if…
You will apply either the new Berovenal® gel dressing or a standard reference gel dressing to your foot ulcer every day for 8 weeks, or until your ulcer closes completely. You'll visit the clinic every 2 weeks for checkups and measurements of your ulcer to see how it's healing. You'll also keep a simple diary to track your symptoms and how often you use the dressing.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Germany
Poland